CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
PROMOTE trains doctoral candidates in -omics and artificial intelligence to enhance prostate cancer management. The project aims to develop non-invasive tools and improved treatment options through molecular characterization, addressing the challenges of over-treatment and under-treatment in prostate cancer patients.
PROMOTE focuses on multidisciplinary education of doctoral candidates (DCs) in -omics and artificial intelligence (AI) mediated intervention to improve clinical management of Prostate Cancer (PCa). PCa is the second most common malignancy, affecting ~1.3 million men every year worldwide.
Tragically, there is a treatment paradox, as ~45% of PCa patients experience slow-growing cancer and are unlikely to progress rapidly, while PCa is not curable at advanced stage.
Evidently, clinical management o…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
BIOMEDICAL RESEARCH FOUNDATION, ACADEMY OF ATHENS
Greece, Athina
Type: Research institute
Activity type: Research Organisations
SME: No
Austria, Innsbruck
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
KRESK TECNOLOGIAS DE INFORMACAO LDA
Portugal, LISBOA
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
